MODELING TOXICITY AND RESPONSE IN CARBOPLATIN-BASED COMBINATION CHEMOTHERAPY

被引：0
|
作者：
EGORIN, MJ
REYNO, LM
CANETTA, RM
JODRELL, DI
SWENERTON, KD
PATER, JL
BURROUGHS, JN
NOVAK, MJ
SRIDHARA, R
机构：
[1] UNIV MARYLAND,SCH MED,DEPT MED,DIV MED ONCOL,BALTIMORE,MD 21201
[2] CANADA CLIN TRIALS GRP,NATL CANC INST,KINGSTON,ON,CANADA
[3] BRISTOL MYERS SQUIBB CO,WALLINGFORD,CT 06492
来源：
SEMINARS IN ONCOLOGY | 1994年 / 21卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：7 / 19
页数：13
相关论文
共 50 条
  • [21] CARBOPLATIN-BASED NEOADJUVANT CHEMOTHERAPY: A REASONABLE ALTERNATIVE FOR CISPLATIN UNFIT PATIENTS?
    Mertens, Laura
    Meijer, Richard
    van Rhijn, Bas
    Bergman, Andries
    Kerst, Martijn
    Horenblas, Simon
    JOURNAL OF UROLOGY, 2012, 187 (04): : E217 - E217
  • [22] Prospective study of carboplatin-based chemotherapy for pediatric germ cell tumors
    Stern, JW
    Bunin, N
    MEDICAL AND PEDIATRIC ONCOLOGY, 2002, 39 (03): : 163 - 167
  • [23] Retrospective review of hearing in children with retinoblastoma treated with carboplatin-based chemotherapy
    Lambert, Michele P.
    Shields, Carol
    Meadows, Anna T.
    PEDIATRIC BLOOD & CANCER, 2008, 50 (02) : 223 - 226
  • [24] Review of carboplatin-based high-dose chemotherapy combinations in the autotransplant setting
    Rodenhuis, S
    vanderWall, E
    Schornagel, JH
    Baars, JW
    PLATINUM AND OTHER METAL COORDINATION COMPOUNDS IN CANCER CHEMOTHERAPY 2, 1996, : 221 - 227
  • [25] Experience with the management of neutropenia in gynecologic cancer patients receiving carboplatin-based chemotherapy
    Markman, J
    Zanotti, K
    Webster, K
    Belinson, J
    Peterson, G
    Kulp, B
    Markman, M
    GYNECOLOGIC ONCOLOGY, 2004, 92 (02) : 592 - 595
  • [26] Superior mesenteric artery syndrome: a unique complication following carboplatin-based chemotherapy
    Chowdhary, Mudit
    Pansuria, Heer P.
    Farooqi, Bilal
    Goyal, Hemant
    INTERNATIONAL MEDICAL CASE REPORTS JOURNAL, 2015, 8 : 55 - 58
  • [27] Carboplatin-based sequential chemotherapy for aged patients with advanced bladder cancer.
    Yoneyama, Takahiro
    Tobisawa, Yuki
    Yoneyama, Tohru
    Yamamoto, Hayato
    Imai, Atsushi
    Mori, Kazuyuki
    Hatakeyama, Shingo
    Hashimoto, Yasuhiro
    Kole, Takuya
    Ohyama, Chikara
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [28] Carboplatin-based chemotherapy in collection CD34+ cells in children.
    Cappelli, C
    Libera, F
    Cosentino, S
    Minori, A
    Clerico, A
    De Fabritiis, P
    Mandelli, F
    Castello, MA
    BONE MARROW TRANSPLANTATION, 1999, 23 : S197 - S197
  • [29] Carboplatin-based chemotherapy in patients with gynecological malignancies on long-term hemodialysis
    Niikura, H
    Koizumi, T
    Ito, K
    Okamura, K
    Yaegashi, N
    ANTI-CANCER DRUGS, 2003, 14 (09) : 735 - 738
  • [30] Carboplatin-based sequential chemotherapy for advanced bladder cancer patient with impaired renal function
    Yoneyama, Takahiro
    Mikami, Jotaro
    Fujita, Naoki
    Sato, Tendo
    Kojima, Yuta
    Iwamura, Hiromichi
    Imai, Atsushi
    Hatakeyama, Shingo
    Hashimoto, Yasuhiro
    Koie, Takuya
    Ohyama, Chikara
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
12345